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BACKGROUND: People with chronic pain frequently have difficulties in completing everyday tasks to 
maintain independence and quality of life. Informal caregivers may provide support to these 
individuals. However, the effectiveness of interventions to train and support these individuals in 
caregiving remains unclear. The purpose of this study was to systematically review the evidence to 
determine the effectiveness of caregiver interventions to support informal caregivers of people with 
chronic pain. 
METHODS: A systematic review of published and unpublished literature databases was undertaken 
(09 April 2021). Trials reporting clinical outcomes of caregiver interventions to train informal 
caregivers to support community-dwelling people with chronic pain were included. Meta-analysis was 
undertaken and each outcome was assessed using GRADE.  
RESULTS: 27 studies were eligible (N=3427 patients). Twenty-four studies assessed patients with 
cancer pain, three with musculoskeletal pain. No other patient groups were identified. There was 
very low-quality evidence that caregiver interventions were beneficial for caregiver health-related 
quality of life (standardised mean difference (SMD): 0.26; 95% confidence intervals (CI): 0.01 to 0.52; 
N=231). There was moderate-quality evidence that caregiving interventions were effective in 
reducing pain in the short-term (SMD 0.16; 95% CI: -0.29 to -0.03There was low-quality evidence 
that caregiving interventions had no beneficial effect over usual care for psychological outcomes, 
fatigue, coping or physical function in the long-term.  
CONCLUSION: Caregiving interventions may be effective for patients and caregivers but only in the 
shorter-term and for a limited number of outcomes. There is insufficient evidence examining the 
effectiveness of caregiver interventions for people with non-cancer related pain.   
 





Chronic pain is complex and multi-factorial in its origin. Previous literature has explored the social 
dynamics between people with chronic pain and their family members and friends.1 People with 
chronic pain frequently have difficulties in managing everyday activities to maintain independence 
and quality of life.2 To assist with these, they often access support or caregiving. Such support may 
include: washing and dressing, preparing meals and assistance in feeding, housework or shopping.3,4 
This caregiving may be formal or informal. Formal care is defined as the provision of care by someone 
who is paid for such a service. Informal care is provided without a direct cost. This is historically either 
a care-recipient’s spouse or partner, family members or friends. In addition to activities which formal 
carers may provide, informal caregivers may also assist in other tasks such as assistance in managing 
money or bills, or other organisational rather than necessarily physical roles.3    
 
Invariably caring for and supporting individuals with chronic pain during day-to-day tasks can have a 
long-term negative impact on them and their caregiver. This can be particularly challenging for 
caregivers of people with chronic cancer pain. The management of nociceptive and neuropathic pain 
associated with cancer pain can be particularly challenging; this is amplified emotionally with the 
stress of caregiving for someone close to that individual who has a life-limiting disease.5 Previous 
evidence has centred on the relationship between older married couples and chronic pain.6,7 Such 
studies have demonstrated that both members of this dyad report greater pain elevated by depressed 
mood, challenges in their marital relationships and heightened distress.1,7 Whybrow et al8 reported 
greater challenges in caregiving and overall dissatisfaction between care-recipients and caregivers 
when the dyad have limited understanding of the presenting medical condition. They suggested that 
caregivers desire training interventions on caring, to improve knowledge on their care-recipient’s 




Given that chronic pain affects the health and wellbeing of both care-recipients and caregivers,10 
interventions to support this dyad are warranted. No systematic reviews have undertaken such an 
analysis irrespective of the cause of chronic pain. The purpose of this study was to address this 
limitation and to systematically review the evidence to determine the effectiveness of 
caregiver interventions to support informal caregivers of people with chronic pain.  
 
MATERIALS AND METHODS 
 
This systematic review was registered through the International Prospective Register of Systematic 
Reviews database (PROSPERO Registration: CRD42019136171) and reported following the Preferred 
Reporting Items for Systematic review and Meta-Analysis (PRISMA) guidelines.11  
Search Strategy 
The search was undertaken by one reviewer (MS) using published and unpublished databases 
including Ovid EMBASE, Ovid MEDLINE, EBSCO CINAHL, OpenGrey, the WHO International Clinical Trial 
Registry and ClinicalTrials.gov registry. The search strategy for EMBASE is presented in Supplementary 
Table 1. This was modified for each database. Reference lists of all potentially eligible studies were 
independently reviewed by two reviewers (TS,MP). Corresponding authors from included studies 
were contacted to identify other studies. The search was conducted from database inception to 09th 
April 2021.  





Two reviewers (MP, TS) independently reviewed all titles and abstracts from the search results. Full-
text papers for all potentially eligible studies were independently reviewed by each reviewer to 
determine final inclusion. Disagreements between the two reviewers were resolved through 
discussion with an adjudicator (SL).  
The eligibility criteria were:  
Inclusion criteria 
• Randomised or non-randomised controlled trials (RCTs) recruiting informal caregivers of 
adults (≥18 years) with chronic pain attributed to any pathological origin. Chronic was defined 
as pain experienced for six months or longer.12 
• Interventions were enhanced informal caregiver training programmes. These were defined as 
interventions aimed to improve the understanding and/or practical skills for informal 
caregivers to manage symptoms of people with chronic pain.  
• Control interventions were either usual care (no caregiver intervention) or a comparative 
intervention such as a non-caregiver training intervention. 
 
Exclusion criteria 
• Caregivers of patients with pain or pain derived from an acute origin including childbirth/acute 
post-surgical. Acute was defined as less than 12 weeks from primary presentation.12  
• Caregivers of patients with cognitive impairment or intellectual disabilities where a caregiver-
patient education programme may require different learning approaches. 
• Interventions which were designed to provide training to paid caregivers or clinical health 





Data were extracted onto a pre-defined data extraction form by two reviewers (MP, JF) and verified 
by a third (TS). Where the same study was reported across two or more papers, these were classified 
as a single study to avoid multiple counting.  
Data extracted included: country of origin; year of study conduct; number and characteristics of care-
recipients including data on: age, gender, principal presenting pathology and medical morbidities 
(when reported); caregiver characteristics including: age and gender; intervention characteristics 
(experimental and control); composition, timing, dosage, staff delivery, duration and format of 
intervention delivered; co-interventions; and outcomes. 
 
Outcome Measures and End-Points 
The primary outcome measure was caregiver health-related quality of life (HRQOL). Secondary 
outcome measures included: care-recipient HRQOL, care-recipient pain and physical function, care-
recipient and caregiver anxiety and depression, caregiver burden, coping, self-efficacy, fatigue, 
perceived stress and cost-effectiveness/health resource utilisation. These diverse outcome domains 
are warranted to ensure that both care-recipient and caregiver outcomes are measured, whilst also 
acknowledging the complex social and health needs which this dyad present.13 
The primary end-point was 12 months (long-term outcome). Outcomes were analysed as short-term 
(zero to three months post-randomisation), or mid-term (three to 12 months post-randomisation).  
 
Risk of Bias Assessment 
Two reviewers (MP, TS) independently critically appraised each included study using the Cochrane 
Risk of Bias tool.14 This assesses the risk of bias in research through an assessment of randomisation 
(selection bias), blinding of participants or personal (performance bias), outcome assessor (detection 
bias), risk of bias attributed to incomplete outcome data (attrition bias), selective reporting (reporting 
 
 
bias) or other potential threats.14 Each is assessed as ‘low risk’, or ‘high risk, or as ‘unclear risk’, 
indicating either lack of information or uncertainty over the potential for bias.14 Disagreements in 
scoring between the two reviewers were resolved through discussion until consensus was reached.  
 
Statistical Analysis 
Data extraction tables were reviewed for study heterogeneity. Through this, between-study variability 
in participant characteristics, interventions and study design were assessed. Where heterogeneous, a 
narrative analysis of the results was presented. Where homogeneous, data were pooled for those 
outcomes using a Mantel-Haenszel approach.15 For continuous outcomes, a standardised mean 
difference (SMD) and 95% confidence intervals (Cis) were reported. For dichotomous outcomes, risk 
ratios (RR) and 95% CIs were presented. All meta-analyses used a random-effect model given the 
nature of caregiver training interventions to offer flexibility to tailor interventions.16 Statistical 
heterogeneity was assessed using the I2 statistic.  
Small sample size publication bias was assessed using funnel plots, when there were a minimum of 10 
studies for each outcome.14 Sensitivity analyses were undertaken for the principal meta-analysis by 
removing studies with both: high risk of bias for detection bias and those which did not present an a 
priori sample size calculation.  
Planned subgroup analyses were:  
(A) Patient diagnosis for example, musculoskeletal pain versus cancer pain 
(B) Type of caregiver intervention (e.g. multicomponent intervention versus single-
component intervention; online versus face-to-face interventions). 
 
All analyses were conducted using RevMan (Review Manager (RevMan) [Computer program]. Version 




Assessment of the Quality of Evidence  
We assessed the quality of evidence for each outcome using the Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE) criteria.17 Through this, the certainty of evidence 
was either increased (upgraded) or decreased (downgraded) against the following five criterion: (1) 
methodological limitations using the Cochrane Risk of Bias tool (downgraded where there was high 
risk of bias for three or more items; upgraded where all items demonstrated low risk of bias); (2) 
indirectness relating to similarity to clinical practice (downgraded where reviewers felt the study 
design was not generalisable to UK practice; upgraded where study design was generalisable to UK 
practice); (3) imprecision relating to the number of participants and events (downgraded where 
outcomes reported less than 300 participants or five events; upgraded where outcomes reported in 
excess of 450 participants or 20 events); (4) inconsistency in effect estimates across trials for a given 
analysis (downgraded where the confidence intervals were four-times the magnitude of the effect 
estimate; upgraded where confidence intervals were two-times the magnitude of the effect estimate); 
and (5) likelihood of publication bias (downgraded when reviewers observed asymmetry in funnel plot 





Search Strategy Results 
A summary of the search results is presented in Figure 1. A total of 7732 titles and abstracts were 






There were sufficient data to assess small sample size publication bias for two outcomes (pain and 
depression). As Figure 2 illustrates, there was moderate evidence of asymmetry for both. The results 
should therefore be viewed with caution for this potential bias. 
 
Characteristics of included studies 
A summary of the 27 included studies is presented in Table 1. This included 26 RCTs and one non-
RCT.18 Final follow-up interval ranged from two weeks19 to 12 months.20,21 Three studies recruited 
people with musculoskeletal pain (osteoarthritis of the lower limb or lumbar spine).20,22,23 Twenty-four 
studies recruited people with cancer.18,19,21,24-44 No other disease-group was identified. 
In total, 3427 (1399 male/1610 female) care-recipients were included. Mahendran18 and Hudson41 did 
not report the number of care-recipients. Hudson et al41 did not report the gender of their patient 
participants. Mean age of the cohorts ranged from 47.4 years30 to 71.8 years.23The number of 
caregivers recruited was 3361 (873 male/1668 female). de Wit et al43 did not report the number of 
caregivers. Gender was not reported in eight trials.20,21,22,27,35,42,43,44 Mean caregiver age ranged from 
42.7 years30 to 73.8 years.23 
Twenty-two studies were conducted in the USA,19-32,34-39,44,45 two studies from Australia,40,41 and single 
studies from Singapore,18 the Netherlands43 and Norway.42 
Experimental interventions are summarised in Supplementary Table 2. Number of contacts between 
healthcare professionals and care-recipients/caregivers as part of the interventions ranged from one34 
to 14 contacts.24 All experimental interventions were designed to provide education and knowledge 
to the caregiving-dyad to improve symptom self-management. Eleven trial interventions were 
delivered solely face-to-face.18,19,20,21,22,23,25,34,35,38,43 Nine employed a psychological element to the 
 
 
intervention such as cognitive behaviour approaches or psychoeducational 
interventions.18,20,22,25,29,30,39,40,41 Three trial experimental interventions were delivered by 
telephone.36,39,45 Two trial interventions were delivered by recorded interventions such as DVD, CD 
materials or a manual.31,32 Ten trial interventions adopted a blended approach of face-to-face and 
telephone interventions24,27,28,29,30,40,41,42 or web-based and telephone calls.37,44 
Comparators included interventions on self-management which were delivered solely to the care-
recipients and not the caregiver in three trials22,23,26 and no-intervention (usual care) in seven 
trials.18,19,21,25,34,40,43 Sixteen trials used a booklet or received general advice rather than the skills-based 
intervention delivered as part of an ‘active’ intervention.20,24,27,28,29,30,31,32,35,36,37,38,41,42,44,45  
 
Risk of Bias Assessment 
A summary of the Cochrane Risk of Bias results is presented in Table 2. The included trials presented 
a high risk of bias for a number of key criteria. Whilst only Mahendran18 presented with a high risk of 
bias for random sequence generation, being a non-RCT, only eight trials (30%) reported concealing 
their allocation.19,24,25,36,37,40,44,45 No trial blinded their care-recipients or caregivers to the intervention 
(as would have been impossible given the nature of this ‘participatory’ intervention). Seven trials 
(26%) blinded their assessors to group allocation.19,21,24,36,41,44,45 There was low risk for attrition bias in 








There was very low-quality (downgraded two levels for risk of bias and imprecision) evidence that 
caregiver interventions were beneficial for caregiver HRQOL (SMD: 0.26; 95% CI: 0.01 to 0.52; N=231; 





There was very low-quality (downgraded two levels for risk of bias and imprecision) evidence that 
caregiver interventions were beneficial for caregiver general health status (SMD: 0.59; 0.08 to 1.10; 
N=62; one trial) in the medium-term. There was low- (downgraded two levels for risk of bias and 
imprecision) to very low-quality evidence (downgraded one level each for risk of bias, imprecision and 
inconsistency) that caregiver interventions were not beneficial compared to usual care for caregiver 
anxiety, depression, fatigue or burden (Table 2).   
 
Care-recipient outcomes 
There was moderate-quality evidence (downgraded one level for risk of bias) that caregiver 
interventions are effective in reducing care-recipient pain in the short-term (SMD: -0.16; 95% -0.29 to 
-0.03; N=1344; 11 trials) and low-quality evidence (downgraded two levels for risk of bias and 
imprecision) that this occurs to a greater effect in the medium-term (SMD: -0.68; 95% CI: -0.99 to -
0.38; N=178; one trial). There was no benefit demonstrated at the long-term follow-up (SMD: 0.07; 




There was low-quality evidence (downgraded two levels for risk of bias and imprecision) that caregiver 
interventions are no more beneficial than usual care in improving patients with chronic pain HRQOL 
in the short- (SMD: 0.18; 95% CI: -0.27 to 0.64; N=213; two trials), medium (SMD: 0.16; 95% CI: -0.09 
to 0.42; N=235; one trial) or long-term (SMD: 0.03; 95% CI: -0.24 to 0.29; N=218; one trial). 
 
There was low (downgraded two levels for risk of bias and imprecision) and very low-quality 
(downgraded one level each for risk of bias, imprecision and inconsistency) evidence reporting the 
outcomes of physical disability and physical function (Table 2). There was no benefit of caregiver 
interventions over usual care for physical function in the short- (SMD: 0.16, 95% CI: -0.01 to 0.34; 
N=485; two trials) or medium-term (SMD: 0.13; 95% CI: -0.40 to 0.66; N=325; two trials). This was 
mirrored with the assessment of physical disability (Table 2). There was low-quality evidence 
(downgraded two levels for risk of bias and imprecision) that caregiver interventions could improve 
social functioning compared to usual care in the short- (SMD: 0.20; 95% CI: 0.02 to 0.38; N=485; three 
trials) and medium-term (SMD: 0.35, 95% CI: 0.10 to 0.61; N=235; one trial). 
 
Care-recipient psychological factors were assessed through four key domains: depression, anxiety, 
stress, self-efficacy. These outcomes were based on moderate (downgraded one level for risk of bias) 
and low-quality evidence (downgraded two levels for risk of bias and imprecision) (Table 2). There 
was no evidence that caregiver interventions benefit patients with chronic pain for psychological 
outcomes compared to usual care (Table 2), principally at short- and medium-term follow-ups. 
 
There was very low-quality evidence (downgraded one level each for risk of bias, imprecision and 
inconsistency) that caregiver interventions are not beneficial over usual care for reducing care-
 
 
recipient fatigue either in the short- (SMD: 0.07, 95% CI: -0.13 to 0.26; N=530; five trials) or medium-
term (SMD: -0.01, 95% CI: -0.36 to 0.34; N=314; three trials). 
 
There was low-quality evidence (downgraded two levels for risk of bias and imprecision) that caregiver 
interventions were beneficial for improving care-recipient perceived coping in the short-term (SMD: 
0.81; 95% CI: 0.39 to 1.23; N=95; two trials). This benefit was not demonstrated at medium- (SMD: 




Subgroup Analysis: Musculoskeletal Pain versus Cancer Pathologies 
Two disease groups were identified. Through this, it was possible to undertake a subgroup analysis of 
outcomes for people with chronic musculoskeletal pain versus chronic cancer pain are presented in 
Supplementary Table 3. The results for people with cancer pain mirror that of the principal analysis 
with reported benefit for caregiver interventions in pain in the short- (SMD: -0.15, 95% CI: -0.29 to -
0.02; N=1225; eight trials) and medium-term (SMD: -0.68, 95% CI: -0.99 to -0.38; N=178; one trial). 
Similarly, there was a benefit of caregiver interventions for social functioning in the short- (SMD: 0.20; 
95% CI: 0.02 to 0.38; N=485; three trials) and medium-term over usual care (SMD: 0.35; 95% CI: 0.10 
to 0.61; N=235; one trial). Caregiver interventions were also beneficial to HRQOL (SMD: 0.26, 95% CI: 
0.01 to 0.52; N=235; one trial) and general health over usual care (SMD: 0.59; 95% CI: 0.08 to 1.10; 
N=62; one trial) in the medium-term. 
The exceptions to the principal analysis were that caregiver interventions for people with cancer 
reduced perceived stress in the medium-term (SMD: 0.34; 95% CI: 0.00 to 0.68; N=136; two trials) and 
physical disability in the long-term (SMD: 0.96; 95% CI: 0.28 to 1.63; N=38; one trial). This was based 
 
 
on very low-quality evidence (downgraded one level each for risk of bias, imprecision and 
inconsistency).  
When patient-reported outcomes for caregiver interventions were assessed for people with 
musculoskeletal pain, there was low-quality evidence (downgraded two levels for risk of bias and 
imprecision) for a benefit in perceived coping for patients allocated to the caregiver interventions 
compared to usual care both in the short- (SMD: 0.81; 95% CI: 0.39 to 1.23; N=95; two trials) and long-
term (SMD: 0.58; 95% CI: 0.01 to 1.15; N=49; one trial). There was low-quality evidence of no benefit 
of caregiver interventions on outcomes including pain, physical disability, psychological disability or 
self-efficacy (Supplementary Table 3).  
 
Subgroup Analysis: Face-to-Face interventions vs. Online/Telephone/Recorded interventions 
It was possible to compare outcomes of face-to-face compared to online/telephone/recorded 
interventions for eight patient-reported outcomes (Supplementary Table 4). The outcomes of both 
approaches were the same for pain, physical disability, depression, anxiety and fatigue when 
measured in the short-term. Interventions which were delivered face-to-face demonstrated benefit 
in medium-term physical function outcomes (SMD: 0.38; 95% CI: 0.12 to 0.64; N=235; one trial) and 
depression (SMD: -0.39, 95% CI: -0.65 to -0.13; N=235; one trial) compared to 
online/telephone/recorded interventions which demonstrate no benefit over usual care. 
 
Whilst the outcomes of caregiver interventions were comparable for short-term anxiety, burden and 
medium-term depression, there was low-quality evidence (downgraded two levels for risk of bias and 
imprecision) that caregiver interventions delivered face-to-face demonstrated beneficial effects on 
short-term caregiver depression (SMD: 0.25, 95% CI: 0.01 to 0.50; N=265; two trials) compared to 






To the best of our knowledge, this is the first study to systematically review and quantify the 
effectiveness of caregiver interventions for people with chronic pain. The evidence is solely based on 
people with cancer or musculoskeletal-derived chronic pain. The findings suggest caregiver 
interventions provide short-term benefit to care-recipients in coping. There was very low-quality 
evidence that caregiver interventions can benefit caregiver general health status and HRQOL. There 
was no beneficial effect of caregiver interventions on caregiver anxiety, depression, fatigue or 
caregiver burden. Caregiver interventions did not provide benefit when measured by care-recipient 
HRQOL, physical function, psychological outcomes or fatigue. The evidence suggests that caregiving 
interventions are effective in reducing care-recipient pain and improving social function within the 
first-year post-intervention. Face-to-face interventions may be more beneficial than caregiver 
interventions which were delivered solely by telephone, online or through recorded interventions 
such as audio recordings, DVDs or manuals. 
 
Comparison with the Literature 
Whilst caregiver interventions may be effective in reducing pain, there is limited evidence that this 
translates into improved physical function or psychological outcomes. It may be anticipated that with 
reduced symptoms, care-recipients would have greater capability to be more physically able.46 Further 
exploration for this mismatch would be valuable. 
Face-to-face interventions demonstrated greater benefit in physical function and depression, with no 
difference to online/telephone/recorded interventions for all other interventions. Whilst face-to-face 
interventions may offer a more personal therapeutic alliance between health professional and care-
 
 
recipients/caregiver, there are issues regarding scalability of delivery and the convenience which 
internet-based approaches can offer.47 Delivering home-based interventions where care-recipients 
and caregivers are not required to travel to appointments are beneficial, particularly providing care-
recipients and caregivers a feeling of independence from formal healthcare services. However, given 
the heterogeneity in care-recipients/caregiver beliefs relating to pain and its management, ensuring 
that such interventions are flexible to the needs of participants is important.48 
 
There is limited evidence on pain management caregiver programmes for people without cancer pain. 
Three studies recruited patients with chronic musculoskeletal pain.20,22,23 All other studies recruited 
people with cancer pain. No other disease-groups have been previously examined. Whilst cancer and 
musculoskeletal chronic pain populations share similar symptoms in pain, there are marked 
differences around health beliefs to movement,49,50,51 disease progression,51,52 prognosis53 and 
fatigue.51 Psychologically, whilst both populations may present with depression and anxiety, the basis 
of these in relation to ongoing healthcare status may differ.49,51 However, there are also marked 
differences between these two populations. This is most notable in the relationships and family 
dynamics between caregivers and individuals with cancer-related chronic pain. In those with cancer-
related pain, caregivers frequently experience high levels of emotional distress as they support 
individuals who they are close to and who are at the end of their lives, often with unplanned health 
care utilisation or emergency department visits which can increase stress and anxiety.52,53 Through 
these differences between cancer and non-cancer associated pain management, further study is 
warranted to explore the role of caregiver interventions for people with musculoskeletal diseases.  
 
Nine studies employed a psychological element to the intervention such as cognitive behaviour 
approaches or psychoeducational interventions.18,20,22,25,29,30,39,40,41 Adopting a psychological principle 
to underpin an intervention would appear important when interventions are aimed to change 
 
 
behaviours or health beliefs regarding pain and symptom management.54 These interventions were 
education and skills/knowledge programmes rather than behaviour change interventions.19,20,22 Given 
that key components to explain positive dyad relationships are based on influencing potential operant 
conditioning contingencies,55 a behaviour change intervention may be warranted. Further exploration 
is a research priority during the development of future caregiver interventions in improving outcomes. 
 
Whilst the majority of interventions were conducted between four to eight 
weeks.18,21,23,27,28,29,30,32,36,41,42,44 However, this ranged in time from a one-off intervention29,37 to as long 
as the caregiver required to acquire the intervention skills,35 with Given et al25 provided a 20-week 
intervention. There is insufficient evidence to indicate whether there is a substantial difference in 
outcome, or whether there are differences in the types of outcome generated for these interventions 
dependant on duration. Whether interventions of longer duration provide greater opportunity for 
caregivers to acquire mastery of caregiver skills to benefit care-recipients with chronic pain, remains 
unclear.   
 
The current evidence-base relates to middle-aged care-recipients and caregivers. Only Martire et al23 
investigated care-recipient/caregiver cohorts who had a mean age above 70 years. Caregivers and 
care-recipients may have different perceptions and capabilities in managing pain.56 Caregivers who 
have physical disabilities or cognitive impairment are more frequently seen in older caregiving 
population.2 These may have unique perspectives on the caregiving dyad. Further study is therefore 
warranted to better understand this potential difference in the caregiving dyad for older people with 





This study presents three key limitations. Firstly, the evidence is derived from North European, North 
American and Australasian cohorts. There remains uncertainty as to whether these findings are 
transferable to other populations, such as those from southern European countries, Africa, Asia or 
South America. These populations may have different perspectives to pain and caregiving.57,58 Such 
analyses would therefore be valuable to explore whether cultural differences are important in the 
chronic pain caregiving dyad. Secondly, there remains limited data on caregiver outcomes, with the 
majority of data presented on patient-reported outcomes. Given that these interventions are dyad 
interventions, exploring outcomes particularly on burden, would be valuable to better understand the 
wider implications of these interventions. Finally, the current evidence-base is focused on cancer- and 
musculoskeletal-derived chronic pain. No studies were identified examining caregiver interventions 
for people with chronic pain caused by conditions such as inflammatory bowel disease, gastic reflux 
or ulcers, endometriosis, Lyme diease or headaches. Whilst all may impact on an individual’s (and 
caregiver’s) physical and mental health, the management of these through caregiver interventions 
may (or may not be) different both in the intervention’s components and/or outcome. Future study 




There is low to very-low quality evidence that these have wider effectiveness on physical and 
psychological wellbeing both on care-recipients with chronic pain and their caregivers. There is 
moderate to low-quality evidence that caregiver interventions are effective for people with chronic 
pain, particularly in managing pain symptoms associated with cancer-related pain. There is a paucity 
of literature examining the effectiveness of caregiver interventions for people with non-cancer related 
pain such as from musculoskeletal disease. The adoption of caregiver interventions for this population 
therefore requires further exploration to better understand what interventions can have the greatest 
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Table 1: Characteristics of included studies 
Study Country of 
origin 










Badger [29] USA 71 71/0 67.0 (9.6) 71 4/65 61.1 (10.9) Prostate cancer 16 weeks 
Badger [28] USA 52 0/52 53 52 21/28 Range: 50, 
51, 53 
Breast cancer 16 weeks 
Badger [30] USA 80 0/80 47.4 (10.5) 80 37/43 42.7 (12.7) Breast cancer 16 weeks 
Badr [32] USA 39 10/29 68.2 (10.3) 39 12/27 51.5 (10.2) Advance lung cancer 8 weeks 
Belgacen [35] USA 67 28/39 59.6 (19.3) 67 N/D N/D Haematological cancer 3 months 
Budin [39] USA 249 0/249 53.8 (11.7) 249 122/87 51.6 (12.0) Breast cancer and their partners 6 months 
Collinge [31] USA 97 23/74 54.7 (11.6) 97 43/54 51.5 (13.6) Cancer 4 weeks 
Given [25]; Kurtz 
[59] 
USA 237 63/172 59.6 (10.5) 237 110/127 55.2 (13.7) Cancer 20 weeks 
Hendrix [38] USA 119 85/34 N/D 120 20/100 N/D Haematological malignancy cancer patients 4 weeks 
Hudson [40] Australia 106 49/57 69.1 (13.5) 106 37/69 60.8 (14.0) Advanced cancer admitted to a community 
(home-based) palliative care service 
8 weeks 
Hudson [41] Australia N/D N/D N/D 298 85/211 (2 
unknown) 
59.0 (13.9) Advanced cancer receiving home-based 
palliative care. 
Death  
Keefe [20,60] USA 88 34/54 62.6 (10.1) 88 N/D N/D Osteoarthritis Knee 12 months 
Keefe [22] USA 72 33/39 Range: 57.6 
to 60.3 
72 N/D N/D Osteoarthritis Knee 12 weeks 
 
 
Keefe [19] USA 78 44/34 60.5 78 30/48 58.5 Advanced cancer 2 weeks 
Mahendran [18] Singapore N/D N/D N/D 97 34/63 N/D Cancer 4 weeks 
Martire [23] USA 24 0/24 71.8 (7.8) 24 24/0 73.8 (6.8) Lower limb or lumbar osteoarthritis 6 weeks 
Mosher [33,45] USA 106 50/56 Range: 63.5 
(7.7) and 
62.0 (8.2) 
106 29/77 Range: 56.3 
(14) and 
56.8 (13) 
Small cell or non-small cell lung cancer 6 weeks 
Mosher [36] USA 50 31/19 Range: 58.9 
(11.5) and 
57.5 (11.7) 
50 17/33 Range: 55.3 
(12.2) and 
52.4 (15.1) 
Stage 4 gastrointestinal cancer 5 weeks 
Northhouse [21] USA 235 235/0 63 (9.1) 235 N/D 59 (9.7)  Prostate cancer 12 months 





Porter [24] USA 233 123/110 65.3 (9.5) 233 72/161 59.3 (12.3) Lung cancer 4 months 
Rustøen [42] Norway 179 92/87 N/D N/D N/D N/D Bone metastases 6 weeks 
Schenker [34] USA 30 15/15 63 (11) 30 14/16 62 (12) Advancer pancreatic cancer 3 months 
Steel [44] USA 261 190/71 61 (11) 261 N/D N/D Hepatocellular, cholangiocarcinoma, 
gallbladder, neuroendocrine, pancreatic, or 
other primary carcinoma that had 
metastasized to the liver 
6 months 
 
Ward [26] USA 161 64/97 58.5 (11.8) 161 64/97 55.6 (14.1) Cancer  4 weeks 
Wells [27] USA 64 42/22 53 (14.5) 64 N/D N/D Cancer 6 months 
Wit [43] Netherlands 313 117/196 55.5 (12.4) N/D N/D N/D Cancer 8 weeks 
F – female; M – male; N –number; N/D – not documented; SD – standard deviation; USA – United States of America; yrs - years 
 
 
Table 2: Summary of the assessment of risk of bias 












Badger [29] Unclear Risk High Risk High Risk High Risk Low Risk Unclear Risk 
Badger [28] Unclear Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Badger [30] Unclear Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Badr [32] Unclear Risk High Risk High Risk Unclear Risk Low Risk Unclear Risk 
Belgacen [35] Unclear Risk High Risk High Risk High Risk Low Risk Unclear Risk 
Budin [39] Low Risk High Risk High Risk High Risk Unclear Risk High Risk 
Collinge [31] Unclear Risk High Risk High Risk Unclear Risk Low Risk Unclear Risk 
Given [25]; Kurtz [59] Low Risk Low Risk High Risk High Risk Unclear Risk Unclear Risk 
Hendrix [38] Low Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Hudson [40] Low Risk Low Risk High Risk High Risk Unclear Risk Unclear Risk 
Hudson [41] Unclear Risk High Risk High Risk Low Risk High Risk High Risk 
Keefe [20,60] Unclear Risk High Risk High Risk High Risk High Risk Unclear Risk 
Keefe [22] Unclear Risk High Risk High Risk High Risk Low Risk Unclear Risk 
Keefe [19] Low Risk Low Risk High Risk Low Risk Unclear Risk Unclear Risk 
Mahendran [18] High Risk High Risk High Risk High Risk High Risk High Risk 
Martire [23] Unclear Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Mosher [33,45] Low Risk Low Risk High Risk Low Risk Low Risk Unclear Risk 
 
 
Mosher [36] Low Risk Low Risk High Risk Low Risk Low Risk Unclear Risk 
Northhouse [21] Unclear Risk High Risk High Risk Low Risk Low Risk Unclear Risk 
Parker [37] Low Risk Low Risk High Risk High Risk Low Risk Unclear Risk 
Porter [24] Low Risk Low Risk High Risk Low Risk Low Risk Unclear Risk 
Rustøen [42] Low Risk High Risk High Risk High Risk Low Risk Low Risk 
Schenker [34] Low Risk High Risk High Risk Unclear Risk Low Risk Low Risk 
Steel [44] Low Risk Low Risk High Risk Low Risk Low Risk Unclear Risk 
Ward [26] Low Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Wells [27] Unclear Risk High Risk High Risk High Risk Unclear Risk Unclear Risk 
Wit [43] Unclear Risk High Risk High Risk High Risk Unclear Risk High Risk 
 
 
Table 3: Meta-analysis results (Principal Analysis) 
 
Outcome Time-point N (Trials) Std MD (95% CI) I2 GRADE 
Interpretation 
Sensitivity Analysis 
N (Trials) Std MD (95% CI) 
Caregiver Outcomes    
Quality of Life Medium-Term 231 (1) 0.26 (0.01, 0.52) NE Very Low 231 (1) 0.26 (0.01, 0.52) 
Longer-Term 218 (1) 0.14 (-0.13, 0.40) NE Very Low 218 (1) 0.14 (-0.13, 0.40) 
Anxiety Short-Term 664 (6) -0.10 (-0.40, 0.20) 65 Low 106 (1) -0.15 (-0.53, 0.23) 
Long-Term 70 (1) 0.35 (-0.12, 0.82) NE Low NA - 
Depression Short-Term 594 (7) -0.01 (-0.33, 0.30) 67 Very Low 106 (1) -0.15 (-0.53, 0.23) 
Medium-Term 587 (5) -0.12 (-0.55, 0.31) 83 Very Low NA - 
Burden Short-Term 472 (8) -0.03 (-0.29, 0.23) 46 Low 233 (3) -0.15 (-0.51, 0.22) 
Medium-Term 314 (3) -0.13 (-0.09, 0.65) 90 Low NA - 
Fatigue Short-Term 66 (1) 0.00 (-6.85, 6.85) NE Very Low NA - 
Medium-Term 66 (1) 4.86 (-3.05, 12.77) NE Very Low NA - 
General Health Medium-Term 62 (1) 0.59 (0.08, 1.10) NE Very Low NA - 
Patient (care-recipient) Outcomes 
Pain Short-Term 1344 (11) -0.16 (-0.29,-0.03) 22 Moderate 184 (2) -0.16 (-0.45, 0.13) 
Medium-Term 178 (1) -0.68 (-0.99, -0.38) NE Low NA - 
Long-Term 49 (1) 0.07 (-0.49, 0.63) NE Low NA - 
Quality of Life Short-Term 213 (2) 0.18 (-0.27, 0.64) 36 Low NA - 
 
 
Medium-Term 235 (1) 0.16 (-0.09, 0.42) NE Low 235 (1) 0.16 (-0.09, 0.42) 
Long-Term 218 (1) 0.03 (-0.24, 0.29) NE Low 218 (1) 0.03 (-0.24, 0.29) 
Physical 
Function 
Short-Term 485 (2) 0.16 (-0.01, 0.34) 0 Low NA - 
Medium-Term 325 (2) 0.13 (-0.40, 0.66) 79 Very Low NA - 
Physical 
Disability 
Short-Term 215 (4) 0.03 (-0.30, 0.36) 28 Very Low NA - 
Long-Term 87 (2) 0.40 (-0.66, 1.46) 83 Very Low NA - 
Social 
Functioning 
Short-Term 485 (3) 0.20 (0.02, 0.38) 0 Low NA - 
Medium-Term 235 (1) 0.35 (0.10, 0.61) NE Low NA - 
Depression Short-Term 812 (10) -0.15 (-0.38, 0.08) 58 Moderate 106 (1) -0.09 (-0.47, 0.29) 
Medium-Term 587 (5) -0.16 ( -0.58, 0.25) 82 Moderate NA - 
Anxiety Short-Term 324 (4) -0.08 (-0.38, 0.23) 46 Low 106 (1) -0.27 (-0.66, 0.11) 
Medium-Term 70 (1) 0.29 (-0.18, 0.76) NE Low NA - 
Perceived Stress Short-Term 146 (2) 0.28 (-0.04, 0.61) 0 Low NA - 
Medium-Term 136 (2) 0.34 (0.00, 0.68) 0 Low NA - 
Fatigue Short-Term 530 (5) 0.07 (-0.13, 0.26) 21 Low 106 (1) 0.24 (-0.14, 0.62) 
Medium-Term 314 (3) -0.01 (-0.36, 0.34) 54 Low NA - 
Self-Efficacy Short-Term 371 (6) 0.28 (-0.03, 0.59) 52 Moderate 156 (2) -0.03 (-0.34, 0.29) 
Medium-Term 235 (1) 0.01 (-0.25, 0.26) NE Low 235 (1) 0.01 (-0.25, 0.26) 
Long-Term 267 (2) 0.04 (-0.30, 0.37) 30 Low 218 (1) -0.07 (-0.34, 0.20) 
Coping Short-Term 95 (2) 0.81 (0.39, 1.23) 0 Low NA - 
 
 
Medium-Term 235 (1) 0.05 (-0.20, 0.31) NE Low 235 (1) 0.05 (-0.20, 0.31) 
Long-Term 267 (2) 0.30 (-0.20, 0.62) 25 Low 218 (1) 0.21 (-0.06, 0.47) 













1. exp Pain/ 
2. pain*.mp.  
3. or/1-2 
3. exp Neoplasms/  
4. (neoplasm* or malignan* or oncolog* or tumo?r or cancer* or carcinoma).ti,ab.5. exp 
Arthritis, Rheumatoid/ 
6. exp Fibromyalgia  
7. exp Osteoarthritis  
8. exp Musculoskeletal Disease/ 
9. exp Arthritis/ 
10. or/3-9 
11. Caregivers/  
12. (care?giver* or carer* or spouse* or spousal or partner* or significant other).ti,ab.  
13. or/6-7  
14. (intervention* or educat* or train*).ti,ab.  
15. and/3,10,13,14  
16. (randomized controlled trial or controlled clinical trial).pt. or (experiment* or control* or 
random* or blind* or mask* or control* study or groups or assign* or allocate* or 
interrupted time series).ti,ab. 
17. exp animals/  
18. humans.sh.  





Supplementary Table 2: Summary of the interventions (experimental and control) delivered in the included trials 
Study Intervention Comparator 
Badger [29] The 8-week telephone interpersonal counselling (TIP-C) intervention was developed from 
standard interpersonal psychotherapy (IPT), combined with cancer education. Master’s 
prepared nurse or social worker with psychiatric and oncology expertise delivered the 
intervention. After the baseline assessment (average of 56 min), sessions averaged 31 min.  
 
The second intervention was an 8-week health 
education attention condition (HEAC), delivered 
over the telephone. Participants received written 
materials from the National Cancer Institute 
about prostate cancer diagnosis and treatments, 
and health-related topics such as nutrition during 
cancer, exercise to decrease fatigue resources for 
cancer survivors, and quitting smoking. Survivors 
received weekly telephone calls to review these 
materials. After the baseline assessment 
(average of 59 min), sessions averaged 28 min 
Badger [28] Group 1: 8 weekly sessions of health education and their partners received 4 sessions every 
other week by telephone.  
Group 2: 8 weekly sessions of one to one counselling by videophone and their partners 
received 4 sessions every other week (30mins). All sessions lasted approximately 30 min. 
Written information was provided additionally.  
Participants received 8 weekly sessions of one to 
one counselling by telephone and their partners 
received 4 sessions every other week  (30mins).  
 
Badger [30] The 8-week telephone interpersonal counselling (TIP-C) intervention was developed from 
standard interpersonal psychotherapy (IPT), combined with cancer education. A bilingual 
masters prepared social worker delivered the intervention 
 
All survivors and their SPs received the health 
education (THE) intervention delivered by two 
bilingual bicultural paraprofessionals. Adult 
educational techniques guided the teaching. 
Standardized educational materials were sent to 
the participants in Spanish or English before the 
first session, and these materials were reviewed 
over the telephone. 
Badr [32] Separate standardized, tailored manuals for patients and caregivers. The manuals were divided 
into 6 sections. The topics were self-care, stress and coping, symptom management, effective 
communication, problem solving, and maintaining and enhancing relationships. Patients and 
Usual care: consists of standard oncologic care 
and primary palliative care for the patient from 
the point of the diagnosis of advanced LC. 
 
 
caregivers in the intervention group each received their own tailored manuals and participated 
together in 6 weekly 60-mins telephone counselling sessions with a trained interventionist 
who had a masters degree in mental health counselling. 
Primary palliative care is provided by the 
patient’s medical oncologist and includes the 
basic management of pain and other symptoms, 
including depression and anxiety, as well as basic 
discussions about the prognosis and goals of 
treatment. In addition, patients may be referred 
to the outpatient supportive oncology practice 
for a specialty palliative care consultation 
according to need as determined by the treating 
oncologist 
Belgacen [35] The caregiver educational programme was based on the teaching of care classified into four 
categories: meal support, nursing care, welfare care, and symptom management. The 
educational sessions took place in the ward where the patient was undergoing treatment and 
elsewhere in the hospital during the rest of their stay. The educational process lasted as long 
as the caregiver needed to acquire the skills to perform care independently.  
Not specified 
Budin [39] Group 1: Standard psychological education by video consisted of four phase-specific 
psychoeducation videos: (a) coping with your diagnosis, (b) recovering from surgery, (c) 
understanding adjuvant therapy, and (d) your ongoing recovery. Consistent with the 
theoretical framework, the content of each video was organized under three broad topics: (a) 
health-relevant information, (b) information on skill development to facilitate effectiveness of 
coping, and (c) psychosocial support. The objectives of the SE by video intervention were to 
provide phase specific evidence-based information that addressed concerns unique to both 
patients with breast cancer and their partners (Hoskins et al., 2001). 
Group 2: Telephone Counselling (TC) intervention was individualized using a crisis intervention 
model designed to enhance the patient’s and partner’s sense of control and mastery over the 
breast cancer experience and its associated events. The TC intervention protocol consists of 
four standardized phase-specific TC sessions for each patient and partner. Separate scripts 
were tailor-made for patients and partners to address the unique phase specific individual 
needs of patients and partners. The sessions were conducted by a nurse interventionist 
trained and supervised in individualized TC approaches. Within a framework of providing 
health-relevant information, skill development, and psychosocial support, the objectives of the 
TC intervention were to (a) reduce anxiety, (b) shape reality-based appraisals, (c) facilitate 
Treatment as usual. 
 
 
coping strategies and attainment of support, (d) process information, (e) encourage adaptive 
behavioural change, (f) promote functional communication, and (g) promote reintegration of a 
holistic concept of self. 
Group 3: Standard psych education + telephone counselling provided disease management 
along with SPE by video and TC as described above. (2) Disease management (DM) was 
standardized across data collection sites; that is, surgeons, radiologists, and oncologists 
adhered to evidence-based national treatment protocols for the diagnosis and treatment of 
breast cancer, thereby ensuring consistency of the DM for the control group and consistency 
of DM, which was provided to patients in the three intervention groups. 
Collinge [31] A multilingual 78-mins DVD and 66-page manual were produced for homebased instruction. 
Content addresses attitudes and communication about touch in cancer, psychological 
preparation for giving and receiving touch, safety precautions, massage techniques for comfort 
and relaxation, acupressure for specific cancer-related symptoms, and practice in the home 
setting. Suggested duration of sessions was 20 mins, but they were told that as little as 5 mins 
could be beneficial.  
Written instructions to read to the patient at 
least three times per week. Suggested duration 
of sessions was 20 min, but they were told that 
as little as 5 min could be beneficial. 
Given [25]; 
Kurtz [59] 
A cognitive behavioural approach, based on Bandura’s framework. 20 weeks of intervention 
with 10 contacts (5 in person and 5 by telephone). Delivered to carer by intervention nurse 
(registered nurse with experience in oncology); focusing on 2 components, prioritizing 
patient’s needs and strategies carers can adopt, and dimensions of burden. 
Standard care – unclear what consisted of. 
Hendrix [38] Caregiver training on strategies for managing patients’ cancer symptoms, with four major 
components: prevention of infection, pain control, maintenance of nutrition, and adequate 
elimination. Tailored to care givers needs. Training lasted 2 to 3 hours and was delivered in 
one to two sessions, depending on caregiver preference 
1 to 2 sessions over 2-3 hours. Provided standard 
information about healthy lifestyle, community 
resources for caregiving, including, but not 
limited to, home health agencies, respite care, 
and caregiver support services. Tailored to 
caregivers needs. 
Hudson [40] Psycho-educational intervention for family. Nurse-delivered intervention consisted of two 
home visits supplemented by a follow-up phone call between the two visits. A caregiver 
guidebook and audiotape were used to complement the nurse interactions.  
 
Usual Care. Included access to 24-hour phone 
advice and emergency visits from nurses in 
addition to pre-scheduled home visits from 




Hudson [41] Psychoeducational intervention and standard care that incorporated tailored information and 
resources given to family caregivers to promote psychological well-being. The intervention was 
delivered in two versions given that in rural and remote areas where, because of limited 
resources, telephone contact rather than face to face may be more feasible. Intervention 1 
consisted of one visit and three phone calls, and intervention two consisted of two visits and 
two phone calls. For both groups, the first contact was a face-to face visit, and in the latter 
group, the final contact was also a home visit. 
Standard care: Comprised multidisciplinary 
specialist support for patients with advanced, 
non-curative disease and their families. Services 
included an initial assessment, scheduled home 
visits and access to a health care professional 
after hours for advice. Specific caregiver support 
strategies varied within services and were not 
always systematic or comprehensive 
Keefe [20,60] Spouse-assisted pain coping skills training; Conventional pain coping strategy training with no 
spouse involvement (all 10-weekly, 2-hour, group sessions). Both pain-coping strategies are 
grounded in cognitive-behaviour principles, led by psychologist and nurse covering attentive 
diversion skills, activity-based skills, cognitive coping strategies.  
Arthritis education-spousal support control (all 
10-weekly, 2-hour sessions). Spouse in 
attendance and covering education but not with 
a cognitive behaviour element. 
Keefe [22] Spouse-assisted pain coping skills training; (12-weekly, 2-hour, group sessions). Pain-coping 
strategies are grounded in cognitive-behaviour principles, led by psychologist and nurse 
covering attentive diversion skills, activity-based skills, cognitive coping strategies.  
12 weekly sessions comprising of Spouse assisted 
pain coping skills plus exercise session consisting 
of strengthening and aerobic activities; exercise 
session alone, or standard care. 
Keefe [19] Patients and their partners in this condition received three face-to-face sessions for training in 
pain management strategies. The sessions were structured to last for 45 to 60 mins and to be 
delivered over approximately one to two weeks. Delivered in the patient’s home by a 
registered nurse-level nurse educator knowledgeable about cancer pain and skilled in coping 
skills training interventions.  
Patients and partners in this condition received 
the routine care provided through their medical 
outpatient or hospice program. 
Mahendran 
[18] 
Pilot psychoeducational support group intervention for family caregivers of cancer patients. 
“COPE” intervention. Four weekly sessions simultaneously targeting psychoeducation, skills 
training, and supportive therapy.  
Waiting list control 
Martire [23] Group Arthritis Self-Help Course (6-weekly, 2-hour sessions). Trained person (professional or 
non-professional) delivering arthritis education (coping and management). Each session also 
had a 20-mins couples’ session which augmented the group session with focus on spouse role.  
Experimental intervention (6-weekly, 2-hour 
sessions) attended by the patient but without 






Telephone Symptom Management. Participants received instruction in symptom management 
strategies. Each person was mailed identical handouts detailing major points discussed during 
the sessions, home practice assignments and a CD with instructions for relaxation exercises. 
This involved 4x45 mins telephone sessions with both carer and participant. 
The primary goal of this intervention was to 
direct participants to resources for practical and 
health information and psychosocial services. 
This involved 4x45 mins telephone sessions with 
both carer and participant. 
Mosher [36] Participants in both study groups were asked to complete five weekly 50 to 60 mins telephone 
sessions. Both dyad members participated simultaneously via speakerphone, and all sessions 
were audio recorded. Dyads in the intervention condition helped create an informational 
resource on various QoL issues for other patients and caregivers coping with cancer over 5 
sessions. Participants used these sessions to create a coping resource for peers.  
Dyads in the coping skills condition discussed the 
same topics as the intervention, but did not help 
create an informational resource for other 
patients and caregivers. 
Northhouse 
[21] 
Standard clinic care plus a family-based intervention called the FOCUS Program, a supportive-
educative intervention. The program consists of 3 x 90-mins home visits and 2 x 30-mins 
telephone sessions spaced 2 weeks apart and delivered between baseline and 4 months 
Control group received standard clinic care at 
their cancer centre that addressed primarily 
diagnosis and treatment of patients’ disease 
Parker [37] Web-based conferencing/ telephone conferencing regarding patient management. An 
assigned hospice staff member (usually a nurse) would give a brief report on the patient’s 
condition and identify any concerns for discussion. Family members were encouraged to 
provide feedback and ask questions before a final plan of care was agreed upon 
No involvement in hospice care meetings. Usual 
care: not documented what this involved. 
Porter [24] 14 telephone-based sessions of caregiver-assisted coping skills training (CST) of 45 mins. 
Involved training in symptom management strategies. Sessions were supplemented with 
written materials (e.g., handouts), provided to the participants before the sessions, which 
highlighted the major points discussed in the sessions and detailed home practice 
assignments. Participants also received a CD (or audiotape) with instructions for progressive 
muscle relaxation. 
Cancer education/ support including the (14 x 45-
mins sessions). The primary goal of this 
intervention was to provide participants with 
information regarding lung cancer and its 
treatment in a supportive environment in which 
patients and caregivers were encouraged to 
discuss the patient’s treatment. Sessions were 
supplemented with handouts summarizing the 
major points and listing additional resources 
(e.g., Web sites and books) 
Rustøen [42] Norwegian version of the PRO-SELF PCP. Nurse-visits in patient’s homes in weeks 1, 3 and 6. At 
the initial session, the nurse identified knowledge deficits to provide knowledge on pain and 
side effect management, how to use weekly pillbox, communication aids with physicians on 
Booklet provided on cancer pain management 
and diary to record pain. Nurse visits in patients’ 
homes at weeks 1, 3 and 6 and telephone calls at 
 
 
pain relief and medication. These were re-enforced and developed in the subsequent sessions. 
Telephone interviews were conducted at weeks 2, 4 and 5. During these educational support 
was re-enforced and skill son pain management provided. Patients completed a pain 
management diary.  
Weeks 2, 4 and 5 to re-enforce the use of the 
diaries.  
Schenker [34] In-person palliative care visits with a specialty-trained palliative care physician. Follow-up 
intervention visits scheduled monthly for the first three months, and as needed thereafter. 
More frequent palliative care visits were allowed in the event that additional needs were 
identified. Visit content included (1) relationships and rapport building; (2) illness 
understanding, preferences, and concerns; (3) patient and caregiver needs, including physical 
symptoms, psychological/ emotional distress, and social/financial/caregiver burden; and (4) 
resources, review, and next steps.  
Usual care included standard oncology care. 
Usual care participants had access to any 
palliative care service that was deemed 
appropriate 
Steel [44] A web-based collaborative care intervention. The web-based collaborative care intervention 
included access to a psychoeducational web site and to a collaborative care coordinator with 
training and experience with cognitive-behavioural therapy (CBT) and psycho-oncology. The 
patient had telephone contact with the care coordinator approximately every 2 weeks and 
face-to-face contact with the care coordinator in the oncology outpatient clinic and/or hospital 
approximately every 2 months. Frequency of visits increased if required.  
Usual care provided by the medical team. if a 
patient or caregiver scored high on the CES-D or 
the BPI average pain score, the patient was 
contacted by a care coordinator and was 
provided education about the symptoms and 
referrals to a mental health professional in the 
patient’s community or to the patient’s 
Primary care physician for pharmacological 
treatment for depression. If the patient scored 
high on the BPI average pain item, the patient 
was referred to a pain centre or an expert in 
symptom management if it was cancer related. 
Ward [26] Solo RIDcancerPAIN + intervention. The intervention was based on the Representational 
Approach to patient education (Donovan 2007). Patient and significant other received 20-80-
minute intervention plus 2 x 5-10 mins follow up calls at 2 weeks and 4 weeks post 
intervention session. Second arm with Solo RIDcancerPAIN+- intervention but without 
significant other. 
Treatment as usual 
Wells [27] Three treatment arms: a) pain education alone, b) pain education with access to a pain hot 
line(4 calls over a month), or c) pain education followed by routine provider-initiated 




telephone follow-up calls. All patients and their caregivers participated in the pain education 
program, 20-30 mins in duration.  
Wit [43] Four study groups were distinguished: (1) a control group without district nursing; (2) an 
intervention group without district nursing; (3) a control group with district nursing; and (4) an 
intervention group with district nursing. Intervention: information was provided in a one-to-
one setting lasting between 30 and 60 mins. Follow up calls made at 3- and 7-days post-
discharge. Intervention was delivered by specialist nurses trained as pain counsellors to 
educate and instruct patients about pain and pain treatment. The intervention aimed to 
improve pain knowledge, reporting and help seeking behaviour. 






Supplementary Table 3: Meta-analysis results (subgroup for trials recruiting people with cancer or 
musculoskeletal pain) 
 
Outcome Time-point N (Trials) Std MD (95% CI) I2 GRADE 
Interpretation 
Caregiver of Patients with Cancer Outcomes 
Quality of Life Medium-Term 235 (1) 0.26 (0.01, 0.52) NE Very Low 
Longer-Term 218 (1) 0.14 (-0.13, 0.40) NE Very Low 
Anxiety Short-Term 664 (6) -0.10 (-0.40, 0.20) 65 Low 
Long-Term 70 (1) 0.35 (-0.12, 0.82) NE Low 
Depression Short-Term 594 (7) -0.01 (-0.33, 0.30) 67 Very Low 
Medium-Term 587 (5) -0.12 (-0.55, 0.31) 83 Very Low 
Burden Short-Term 448 (7) -0.03 (-0.31, 0.26) 54 Low 
Medium-Term 314 (3) -0.13 (-0.90, 0.65) 90 Low 
Fatigue Short-Term 66 (1) 0.00 (-0.48, 0.48) NE Very Low 
Medium-Term 66 (1) 0.29 (-0.19, 0.78) NE Very Low 
General Health Medium-Term 62 (1) 0.59 (0.08, 1.10) NE Very Low 
Patients (care-recipients) in Cancer Outcomes 
Pain Short-Term 1225 (8) -0.15 (-0.29, -0.02) 25 Moderate 
Medium-Term 178 (1) -0.68 (-0.99, -0.38) NE Low 
Quality of Life Short-Term 213 (2) 0.18 (-0.27, 0.64) 36 Low 
Medium-Term 235 (1) 0.16 (-0.09, 0.42) NE Low 
Long-Term 218 (1) 0.03 (-0.24, 0.29) NE Low 
Physical Function Short-Term 485 (3) 0.16 (-0.01, 0.34) 0 Low 
Medium-Term 325 (2) 0.13 (-0.40, 0.66) 79 Very Low 
Physical Disability Short-Term 134 (2) 0.09 (-0.40, 0.58) 43 Very Low 
Long-Term 38 (1) 0.96 (0.28, 1.63) NE Very Low 
Social Functioning Short-Term 485 (3) 0.20 (0.02, 0.38) 0 Low 
Medium-Term 235 (1) 0.35 (0.10, 0.61) NE Low 
Long-Term 218 (1) -0.07 (-0.34, 0.20) NE Low 
Depression Short-Term 788 (9) -0.16 (-0.41, 0.08) 62 Moderate 
Medium-Term 587 (5) -0.16 (-0.58, 0.25) 82 Moderate 
 
 
Anxiety Short-Term 324 (4) -0.08 (-0.38, 0.23) 46 Low 
Medium-Term 70 (1) 0.29 (-0.18, 0.78) NE Low 
Perceived Stress Short-Term 146 (2) 0.28 (-0.04, 0.61) 0 Low 
Medium-Term 136 (2) 0.34 (0.00, 0.68) 0 Low 
Fatigue Short-Term 530 (5) 0.07 (-0.13, 0.26) 21 Very Low 
Medium-Term 314 (3) -0.01 (-0.36, 0.34) 54 Very Low 
Self-Efficacy Short-Term 255 (1) 0.11 (-0.13, 0.36) 0 Moderate 
Medium-Term 235 (1) 0.01 (-0.25, 0.26) NE Low 
Coping Medium-Term 235 (1) 0.05 (-0.20, 0.31) NE Low 
Long-Term 218 (1) 0.21 (-0.06, 0.47) NE Low 
Caregiver of Patients with Cancer Outcomes 
Quality of Life Medium-Term 235 (1) 0.26 (0.01, 0.52) NE Very Low 
Longer-Term 218 (1) 0.14 (-0.13, 0.40) NE Very Low 
Anxiety Short-Term 664 (6) -0.10 (-0.40, 0.20) 65 Low 
Long-Term 70 (1) 0.35 (-0.12, 0.82) NE Low 
Depression Short-Term 594 (7) -0.01 (-0.33, 0.30) 67 Very Low 
Medium-Term 587 (5) -0.12 (-0.55, 0.31) 83 Very Low 
Burden Short-Term 448 (7) -0.03 (-0.31, 0.26) 54 Low 
Medium-Term 314 (3) -0.13 (-0.90, 0.65) 90 Low 
Fatigue Short-Term 66 (1) 0.00 (-0.48, 0.48) NE Very Low 
Medium-Term 66 (1) 0.29 (-0.19, 0.78) NE Very Low 
General Health Medium-Term 62 (1) 0.59 (0.08, 1.10) NE Very Low 
Patients (care-recipients) with Musculoskeletal Pain 
Pain Short-Term 119 (3) 0.24 (-0.73, 0.25) 41 Moderate 
Long-Term 49 (1) 0.07 (-0.49, 0.63) NE Low 
Physical Disability Short-Term 81 (2) 0.09 (-0.83, 0.64) 58 Low 
Long-Term 49 (1) 0.112 (-0.68, 0.44) NE Low 
Psychological Disability Short-Term 119 (3) 0.13 (-0.71, 0.45) 57 Low 
Long-Term 49 (1) 0.04 (-0.61, 0.52) NE Low 
Self-Efficacy Short-Term 116 (3) 0.61 (-0.06, 1.28) 65 Low 
Long-Term 49 (1) 0.31 (-0.25, 0.87) NE Low 
 
 
Coping Short-Term 95 (2) 0.81 (0.39, 1.23) 0 Low 
Long-Term 49 (1) 0.58 (0.01, 1.15) NE Low 
CI – confidence interval; I2 – inconsistency value; N – number; NA – not assessed; NE – not estimated; Std MD 
– standardised mean difference 
 
 
Supplementary Table 4: Subgroup analysis by face-to-face vs. online/telephone/recorded delivery 
approaches 
 
Outcome Time-point Face-to-Face Online/Telephone/Recorded  
N (Trials) Std MD (95% CI) I2 N (Trials) Std MD (95% CI) I2 
Caregiver of Patients with Cancer Outcomes  
Quality of Life Medium-Term 235 (1) 0.26 (0.01, 0.52) NE NA - - 
Longer-Term 218 (1) 0.14 (-0.13, 0.40) NE NA - - 
Anxiety Short-Term 105 (2) 0.07 (-0.38, 0.53) 19 559 -0.19 (-0.59, 0.21) 76 
Long-Term NA - - 49 (1) 0.07 (-0.49, 0.63) NE 
Depression Short-Term 265 (2) 0.25 (0.01, 0.50) 0 329 (5) -0.14 (-0.58, 0.29) 73 
Medium-Term 235 (1) -0.04 (-0.30, 0.21) NE 352 (4) -0.16 (-0.79, 0.48) 87 
Burden Short-Term 107 (2) -0.10 (-1.00, 0.80) 76 341 (5) 0.03 (-0.26, 0.32) 42 
Medium-Term NA - - 314 (3) -0.13 (-0.90, 0.65) 90 
Fatigue Short-Term NA - - 66 (1) 0.00 (-0.48, 0.48) NE 
Medium-Term NA - - 66 (1) 0.29 (-0.19, 0.78) NE 
General Health Medium-Term NA - - 62 (1) 0.59 (0.08, 1.10) NE 
Patients (care-recipients) in Cancer Outcomes 
Pain Short-Term 690 (5) -0.15 (-0.36, 0.07) 48 535 (3) -0.14 (-0.31, 0.03) 0 
Medium-Term 178 (1) -0.68 (-0.99, -0.38) NE NA - - 
Quality of Life Short-Term 213 (2) 0.18 (-0.27, 0.64) 36 NA - - 
Medium-Term 235 (1) 0.16 (-0.09, 0.42) NE NA - - 
Long-Term 218 (1) 0.03 (-0.24, 0.29) NE NA - - 
Physical Function Short-Term 485 (3) 0.16 (-0.01, 0.34) 0 NA - - 
Medium-Term 235 (1) 0.38 (0.12, 0.64) NE 90 (1) -0.16 (-0.58, 0.25) NE 
Physical Disability Short-Term 38 (1) 0.41 (-0.23, 1.06) NE 96 (1) -0.10 (-0.50, 0.30) NE 
Long-Term NA - - 38 (1) 0.96 (0.28, 1.63) NE 
Social Functioning Short-Term 485 (3) 0.20 (0.02, 0.38) 0 NA - - 
Medium-Term 235 (1) 0.35 (0.10, 0.61) NE NA - - 
Depression Short-Term 364 (3) -0.17 (-0.37, 0.04) 0 424 (6) -0.21 (-0.60, 0.19) 75 
Medium-Term 235 (1) -0.39 (-0.65, -0.13) NE 352 (4) -0.08 (-0.69, 0.52) 86 
Anxiety Short-Term 99 (1) 0.22 (-0.17, 0.62) NE 225 (3) -0.19 (-0.51, 0.13) 28 
 
 
Medium-Term NA - - 70 (1) 0.29 (-0.18, 0.78) NE 
Perceived Stress Short-Term NA - - 146 (2) 0.28 (-0.04, 0.61) 0 
Medium-Term NA - - 136 (2) 0.34 (0.00, 0.68) 0 
Fatigue Short-Term 183 (1) 0.03 (-0.26, 0.32) NE 347 (4) 0.09 (-0.19, 0.36) 39 
Medium-Term NA - - 314 (3) -0.01 (-0.36, 0.34) 54 
Self-Efficacy Short-Term 99 (1) 0.34 (-0.06, 0.73) NE 156 (2) -0.03 (-0.34, 0.29) 0 
Medium-Term 235 (1) 0.01 (-0.25, 0.26) NE NA - - 
Long-Term 218 (1) -0.07 (-0.34, 0.20) NE NA - - 
Coping Medium-Term 235 (1) 0.05 (-0.20, 0.31) NE NA - - 
Long-Term 218 (1) 0.21 (-0.06, 0.47) NE NA - - 
CI – confidence interval; I2 – inconsistency value; N – number; NA – not assessed; NE – not estimated; Std MD 
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TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Title 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
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INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Intro Para 1&2 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
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Methods Para 
1 
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Methods; Data 
Extraction 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
Methods; Data 
Extraction 
Risk of bias in individual 
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